Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

EBR:GBLB - Euronext Brussels - BE0003797140 - Common Stock - Currency: EUR

73.2  -0.25 (-0.34%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GBLB. GBLB was compared to 46 industry peers in the Financial Services industry. The financial health of GBLB is average, but there are quite some concerns on its profitability. GBLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GBLB was profitable.
In the past year GBLB had a positive cash flow from operations.
Of the past 5 years GBLB 4 years were profitable.
Each year in the past 5 years GBLB had a positive operating cash flow.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

GBLB's Return On Assets of 0.37% is on the low side compared to the rest of the industry. GBLB is outperformed by 69.57% of its industry peers.
With a Return On Equity value of 0.73%, GBLB is not doing good in the industry: 67.39% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 1.80%, GBLB is doing worse than 63.04% of the companies in the same industry.
GBLB had an Average Return On Invested Capital over the past 3 years of 0.81%. This is significantly below the industry average of 9.04%.
The 3 year average ROIC (0.81%) for GBLB is below the current ROIC(1.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROIC 1.8%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

With a Profit Margin value of 1.03%, GBLB is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of GBLB has declined.
The Operating Margin of GBLB (7.50%) is worse than 63.04% of its industry peers.
In the last couple of years the Operating Margin of GBLB has declined.
The Gross Margin of GBLB (66.90%) is better than 60.87% of its industry peers.
In the last couple of years the Gross Margin of GBLB has remained more or less at the same level.
Industry RankSector Rank
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBLB is destroying value.
The number of shares outstanding for GBLB has been reduced compared to 1 year ago.
GBLB has less shares outstanding than it did 5 years ago.
GBLB has a worse debt/assets ratio than last year.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that GBLB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.45, GBLB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
GBLB has a debt to FCF ratio of 10.80. This is a negative value and a sign of low solvency as GBLB would need 10.80 years to pay back of all of its debts.
GBLB has a Debt to FCF ratio (10.80) which is in line with its industry peers.
A Debt/Equity ratio of 0.48 indicates that GBLB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.48, GBLB is in line with its industry, outperforming 47.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Altman-Z 1.45
ROIC/WACC0.31
WACC5.75%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GBLB has a Current Ratio of 1.95. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GBLB (1.95) is better than 73.91% of its industry peers.
GBLB has a Quick Ratio of 1.58. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
GBLB's Quick ratio of 1.58 is fine compared to the rest of the industry. GBLB outperforms 73.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.58
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

The earnings per share for GBLB have decreased strongly by -96.80% in the last year.
Measured over the past years, GBLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.51% on average per year.
Looking at the last year, GBLB shows a decrease in Revenue. The Revenue has decreased by -1.35% in the last year.
The Revenue has been growing slightly by 3.51% on average over the past years.
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%

3.2 Future

The Earnings Per Share is expected to decrease by -14.59% on average over the next years. This is quite bad
Based on estimates for the next years, GBLB will show a small growth in Revenue. The Revenue will grow by 2.33% on average per year.
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 107.65, the valuation of GBLB can be described as expensive.
GBLB's Price/Earnings ratio is a bit more expensive when compared to the industry. GBLB is more expensive than 73.91% of the companies in the same industry.
GBLB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.18.
Based on the Price/Forward Earnings ratio of 20.86, the valuation of GBLB can be described as rather expensive.
Based on the Price/Forward Earnings ratio, GBLB is valued a bit more expensive than 60.87% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, GBLB is valued a bit cheaper.
Industry RankSector Rank
PE 107.65
Fwd PE 20.86
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBLB is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
GBLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GBLB is cheaper than 65.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.05
EV/EBITDA 9.33
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as GBLB's earnings are expected to decrease with -14.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%

5

5. Dividend

5.1 Amount

GBLB has a Yearly Dividend Yield of 4.73%, which is a nice return.
Compared to an average industry Dividend Yield of 3.93, GBLB pays a better dividend. On top of this GBLB pays more dividend than 80.43% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.73%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

346.34% of the earnings are spent on dividend by GBLB. This is not a sustainable payout ratio.
GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP346.34%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (7/16/2025, 5:35:15 PM)

73.2

-0.25 (-0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-02 2025-05-02
Earnings (Next)07-31 2025-07-31
Inst Owners26.43%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap9.75B
Analysts83.08
Price Target87.98 (20.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.73%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP346.34%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.26%
PT rev (3m)-3.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 107.65
Fwd PE 20.86
P/S 0.98
P/FCF 13.05
P/OCF 7.34
P/B 0.69
P/tB 1.36
EV/EBITDA 9.33
EPS(TTM)0.68
EY0.93%
EPS(NY)3.51
Fwd EY4.79%
FCF(TTM)5.61
FCFY7.66%
OCF(TTM)9.98
OCFY13.63%
SpS74.79
BVpS106.03
TBVpS53.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROCE 3.05%
ROIC 1.8%
ROICexc 2.1%
ROICexgc 3.14%
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
FCFM 7.5%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexcg growth 3Y-6.63%
ROICexcg growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Debt/EBITDA 5.21
Cap/Depr 104.41%
Cap/Sales 5.84%
Interest Coverage 2.06
Cash Conversion 101.89%
Profit Quality 728.78%
Current Ratio 1.95
Quick Ratio 1.58
Altman-Z 1.45
F-Score8
WACC5.75%
ROIC/WACC0.31
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A
EBIT growth 1Y-30.37%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year9.24%
EBIT Next 3Y5.06%
EBIT Next 5YN/A
FCF growth 1Y60.4%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y18.45%
OCF growth 3Y8.48%
OCF growth 5Y4.55%